These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 20079752)

  • 1. Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease.
    Bales KR
    Neuropharmacology; 2010; 59(4-5):295-302. PubMed ID: 20079752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E protects cultured pericytes and astrocytes from D-Abeta(1-40)-mediated cell death.
    Bruinsma IB; Wilhelmus MM; Kox M; Veerhuis R; de Waal RM; Verbeek MM
    Brain Res; 2010 Feb; 1315():169-80. PubMed ID: 20034483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent effects of APOE on cholesterol metabolism and brain Abeta levels in an Alzheimer disease mouse model.
    Mann KM; Thorngate FE; Katoh-Fukui Y; Hamanaka H; Williams DL; Fujita S; Lamb BT
    Hum Mol Genet; 2004 Sep; 13(17):1959-68. PubMed ID: 15229191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
    Fan J; Donkin J; Wellington C
    Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain.
    Ramassamy C; Averill D; Beffert U; Theroux L; Lussier-Cacan S; Cohn JS; Christen Y; Schoofs A; Davignon J; Poirier J
    Neurobiol Dis; 2000 Feb; 7(1):23-37. PubMed ID: 10671320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
    J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
    Baum L; Chen L; Ng HK; Pang CP
    Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ApoE: the link between Alzheimer's-related glucose hypometabolism and Aβ deposition?
    Patil SP; Ballard R; Sanchez S; Osborn J; Santangelo D
    Med Hypotheses; 2012 Apr; 78(4):494-6. PubMed ID: 22285195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The apolipoprotein E ε4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase.
    Darreh-Shori T; Modiri N; Blennow K; Baza S; Kamil C; Ahmed H; Andreasen N; Nordberg A
    Neurobiol Aging; 2011 Jul; 32(7):1236-48. PubMed ID: 19713000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease.
    Kamboh MI
    Hum Biol; 1995 Apr; 67(2):195-215. PubMed ID: 7729825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E in the brain and its role in Alzheimer's disease.
    Poirier J
    J Psychiatry Neurosci; 1996 Mar; 21(2):128-34. PubMed ID: 8820179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease.
    Dodart JC; Marr RA; Koistinaho M; Gregersen BM; Malkani S; Verma IM; Paul SM
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1211-6. PubMed ID: 15657137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E epsilon4 is associated with atrophy of the amygdala in Alzheimer's disease.
    Basso M; Gelernter J; Yang J; MacAvoy MG; Varma P; Bronen RA; van Dyck CH
    Neurobiol Aging; 2006 Oct; 27(10):1416-24. PubMed ID: 16182410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease.
    Poirier J
    Neurobiol Aging; 2005 Mar; 26(3):355-61. PubMed ID: 15639314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOE and cholesterol homeostasis in Alzheimer's disease.
    Leduc V; Jasmin-Bélanger S; Poirier J
    Trends Mol Med; 2010 Oct; 16(10):469-77. PubMed ID: 20817608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.
    Vuletic S; Peskind ER; Marcovina SM; Quinn JF; Cheung MC; Kennedy H; Kaye JA; Jin LW; Albers JJ
    J Neurosci Res; 2005 May; 80(3):406-13. PubMed ID: 15795933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease: the cholesterol connection.
    Puglielli L; Tanzi RE; Kovacs DM
    Nat Neurosci; 2003 Apr; 6(4):345-51. PubMed ID: 12658281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele.
    Pahnke J; Walker LC; Schroeder E; Vogelgesang S; Stausske D; Walther R; Warzok RW
    Acta Neuropathol; 2003 Jan; 105(1):25-9. PubMed ID: 12471457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acids, lipid metabolism and Alzheimer pathology.
    Hooijmans CR; Kiliaan AJ
    Eur J Pharmacol; 2008 May; 585(1):176-96. PubMed ID: 18378224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.